Table 2 Burden of self-reported acute and persistent symptoms stratified by age and sex.
From: Sex and age affect acute and persisting COVID-19 illness
Total (N = 97) | Younger adults (< 60 y.o.) | Older adults (60 + y.o.) | P value | |||||
|---|---|---|---|---|---|---|---|---|
Female (N = 48) | Male (N = 23) | Female (N = 14) | Male (N = 12) | Age | Sex | Age × Sex | ||
Acute symptoms, median (Min–Max) | ||||||||
Total symptoms | 9 (0–19) | 11 (0–16) | 7 (0–17) | 10 (0–19) | 6 (4–9) | .7 | .001 | .3 |
Persistent symptoms, median (Min–Max) | ||||||||
Time from acute symptom onset to clinic visit, months | 9 (3–21) | 9 (3–18) | 9 (3–21) | 9 (5–20) | 8 (4–18) | .6 | .06 | .05 |
Physical symptoms | 1 (0–6) | 2 (0–6) | 1 (0–4) | 1 (0–4) | 1 (0–3) | .07 | .5 | .8 |
Short term memory symptoms | 3 (0–4) | 3 (0–4) | 3 (0–4) | 3 (0–4) | 2 (0–3) | .2 | .1 | 1 |
Executive function symptoms | 3 (0–6) | 3 (0–5) | 3 (0–5) | 3.5 (2–6) | 2.5 (0–4) | .8 | .1 | .4 |
Language symptoms | 2 (0–5) | 2 (0–5) | 2 (0–4) | 2 (0–5) | 2 (0–4) | .7 | .3 | 1 |
Visuospatial symptoms | 0 (0–2) | 0 (0–2) | 0 (0) | 0 (0–1) | 0 (0) | NA | NA | NA |
Personality symptoms | 0 (0–3) | 0 (0–3) | 0 (0–2) | 0 (0–3) | 0 (0–1) | NA | NA | NA |
Neuropsychiatric symptoms | 5 (0–9) | 5 (0–8) | 4 (0–9) | 4 (1–9) | 4 (0–8) | .9 | .3 | .9 |
Neurological symptoms | 3 (0–11) | 3 (1–8) | 2 (0–7) | 3 (0–11) | 2 (0–7) | .8 | .1 | .9 |
Total symptoms | 18 (2–37) | 20 (2–33) | 15 (2–25) | 16 (7–37) | 13.5 (3–25) | .08 | < .001 | .4 |
